Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

309
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
309
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

649
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
649
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

249
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
249

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Composite metabolic indices and calcium oxalate stone formation: a multicenter comparative study of HOMA-IR, PAI, TyG, and METS-IR.

International urology and nephrology·2026
Same author

Assessment of anatomical outcomes in the upper urinary tract following flexible ureteroscopy with flexible and navigable suction ureteral access sheath: 1-year results from a multicentre study.

BJUI compass·2026
Same author

Impact of Different Surveillance Intervals on Recurrence and Progression in Intermediate-Risk Non-Muscle-Invasive Bladder Cancer.

Clinical genitourinary cancer·2026
Same author

Rates of incidental prostate cancer following HoLEP Can it be predicted preoperatively?

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same author

Can flexible nephroscopy, inspection, and calyceal examination (NICE) post suction mini percutaneous nephrolithotomy improve zero and overall stone free rate? an EAU endourology and AUSET collaboration study.

World journal of urology·2026
Same author

Feasibility and efficiency of the use of pulsed thulium: YAG (Thulio) laser for ECIRS: a multicenter evaluation.

World journal of urology·2026

Related Experiment Video

Updated: Feb 23, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.1K

Erectile dysfunction in the elderly male.

Mehmet İlker Gökçe1, Önder Yaman1

  • 1Department of Urology, Ankara University School of Medicine, Ankara, Turkey.

Turkish Journal of Urology
|September 2, 2017
PubMed
Summary

Erectile dysfunction (ED) is increasingly common in older men due to age-related changes and risk factors like hypertension and diabetes. This review covers age-related ED, offering evaluation and treatment guidance.

Keywords:
Atherosclerosisdiabetes mellituserectile dysfunctionhypogonadism

More Related Videos

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

15.2K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.0K

Related Experiment Videos

Last Updated: Feb 23, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.1K
Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

15.2K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.0K

Area of Science:

  • Gerontology
  • Urology
  • Cardiovascular Medicine

Background:

  • Erectile dysfunction (ED) is a prevalent health concern, particularly affecting the aging male population.
  • Increased life expectancy contributes to a higher incidence of ED in elderly men.
  • Key risk factors for ED, including hypertension, dyslipidemia, diabetes mellitus, and atherosclerotic heart disease, are also more common in older adults.

Purpose of the Study:

  • To review the age-related physiological and pathological changes contributing to erectile dysfunction.
  • To provide updated recommendations for the comprehensive evaluation of elderly men with ED.
  • To outline current evidence-based treatment strategies for managing ED in the aging population.

Main Methods:

  • Systematic literature review of studies focusing on aging and erectile dysfunction.
  • Analysis of epidemiological data on ED prevalence in elderly populations.
  • Synthesis of clinical guidelines and expert consensus on ED evaluation and management.

Main Results:

  • Age-related vascular, neurological, and hormonal changes significantly impact erectile function.
  • Comorbidities prevalent in older men (hypertension, diabetes) are major contributors to ED.
  • Effective management strategies exist, tailored to the specific needs and comorbidities of elderly patients.

Conclusions:

  • ED is a significant health issue in aging men, closely linked to common chronic diseases.
  • A thorough evaluation considering age-related factors and comorbidities is crucial for effective ED treatment.
  • Current treatment options can significantly improve quality of life for elderly men experiencing ED.